By analyzing existing essential indicators between Rewalk Robotics and Dexcom, you can compare the effects of market volatilities on both companies' prices and check if they can diversify away market risk if combined in one of your portfolios. You can also utilize pair trading strategies for matching a long position in Dexcom with a short position in Rewalk Robotics. Check out our
pair correlation module for more information.
Let's begin by analyzing the assets.
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Rewalk Robotics has an asset utilization ratio of 23.23 percent. This signifies that the company is making $0.23 for each dollar of assets. An increasing asset utilization means that Rewalk Robotics is more efficient with each dollar of assets it utilizes for everyday operations.
Investment perspective, in general, refers to a viewpoint or opinion regarding investment opportunity in Rewalk Robotics. It encompasses the assessment of an investment's potential risks and rewards, and expectations for its
performance over time. Several factors influence the investment perspective on Rewalk Robotics, including investment goals, risk tolerance, time horizon, market conditions, and research and analysis. Investors have varying goals, such as capital preservation, income generation, or long-term growth. Risk tolerance plays a significant role in shaping an investor's perspective, with some being more risk-averse and others willing to take on higher risks for potential returns.
Watch out for price decline
Please consider monitoring Rewalk Robotics on a daily basis if you are holding a position in it. Rewalk Robotics is trading at a penny-stock level, and the possibility of delisting is much higher compared to other delisted stocks. However, just because the stock is trading under one dollar, does not mean it will be marked for deletion.
Most exchanges require public instruments, such as Rewalk Robotics stock to be traded above the $1 level to remain listed. If Rewalk Robotics stock price falls below $1 for 30 consecutive trading days, the exchange can delist it. Once the company reaches this point, they will be sent an initial price violation notice directly from an exchange.
How important is Rewalk Robotics's Liquidity
Rewalk Robotics
financial leverage refers to using borrowed capital as a funding source to finance Rewalk Robotics ongoing operations. It is usually used to expand the firm's asset base and generate returns on borrowed capital. Rewalk Robotics financial leverage is typically calculated by taking the company's all interest-bearing debt and dividing it by total capital. So the higher the debt-to-capital ratio (i.e., financial leverage), the riskier the company. Financial leverage can amplify the potential profits to Rewalk Robotics' owners, but it also increases the potential losses and risk of financial distress, including bankruptcy, if the firm cannot cover its debt costs. The degree of Rewalk Robotics' financial leverage can be measured in several ways, including by ratios such as the debt-to-equity ratio (total debt / total equity), equity multiplier (total assets / total equity), or the debt ratio (total debt / total assets). Please check the
breakdown between Rewalk Robotics's total debt and its cash.
An Additional Perspective On Rewalk Robotics
Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include product or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
Revenue Breakdown
Lets now take a look at Rewalk Robotics revenue. Based on the latest financial disclosure, Rewalk Robotics reported 5.94
M of revenue. This is 99.92% lower than that of the Healthcare sector and 99.77% lower than that of the
Medical Devices industry. The revenue for all United States stocks is 99.94% higher than that of the company. As for Dexcom we see revenue of 2.32
B, which is 9.05% lower than that of the Medical Devices
| RWLK | 5.94 Million | 0.12 |
| Sector | 2.55 Billion | 52.31 |
| DXCM | 2.32 Billion | 47.57 |
Our perspective of the recent Rewalk Robotics surge
Recent Total Risk Alpha is up to -0.05. Price may plunge again.
As of the 13th of May 2022, Rewalk Robotics holds the
risk adjusted performance of
(0.18), and Coefficient Of Variation of
(687.94). Compared to
fundamental indicators, the
technical analysis model allows you to check existing technical drivers of Rewalk Robotics, as well as the relationship between them. Put it differently, you can use this information to find out if the company will indeed mirror its model of past market data, or the prices will eventually revert. We were able to break down and interpolate nineteen
technical drivers for Rewalk Robotics, which can be compared to its competitors. Please check
Rewalk Robotics coefficient of variation, as well as the
relationship between the treynor ratio and
semi variance to decide if Rewalk Robotics is priced some-what accurately, providing market reflects its current price of 0.95 per share. Given that Rewalk Robotics is a hitting penny stock territory we advise to closely look at its
total risk alpha.
Although some firms in the medical devices industry are either recovering or due for a correction, Rewalk Robotics may not be performing as strong as the other in terms of long-term growth potentials. The inconsistency in the assessment between current Rewalk valuation and our trade advice on Rewalk Robotics is due to the recent market swings and your selection of investing horizon. Please use our equity advice module to run different scenarios to ensure your current risk level and investment horizon are fully reflective of your current investing preferences in regards to Rewalk Robotics.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectEditorial Staff
Vlad Skutelnik is a Macroaxis Contributor. Vlad covers stocks, funds, cryptocurrencies, and ETFs that are traded in North America, focusing primarily on fundamentals, valuation and market volatility. He has many years of experience in fintech, predictive investment analytics, and risk management.
View Profile This story should be regarded as informational only and should not be considered a solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Macroaxis LLC and Vlad Skutelnik do not own shares of Rewalk Robotics. Please refer to our
Terms of Use for any information regarding our disclosure principles.
Would you like to provide feedback on the content of this article?
You can get in touch with us directly or send us a quick note via email to
[email protected]
